ENDRA Life Sciences Inc (NASDAQ:NDRA) Director Buys 9,500 Shares of Stock

ENDRA Life Sciences Inc (NASDAQ:NDRA) Director Michael Harsh bought 9,500 shares of ENDRA Life Sciences stock in a transaction on Friday, June 7th. The shares were purchased at an average cost of $1.11 per share, for a total transaction of $10,545.00. The purchase was disclosed in a filing with the SEC, which is available at the SEC website.

Shares of NASDAQ NDRA traded up $0.23 during mid-day trading on Thursday, hitting $1.46. The company had a trading volume of 498,421 shares, compared to its average volume of 120,511. ENDRA Life Sciences Inc has a 12 month low of $0.90 and a 12 month high of $5.75.

ENDRA Life Sciences (NASDAQ:NDRA) last announced its quarterly earnings results on Monday, March 11th. The company reported ($0.28) earnings per share (EPS) for the quarter.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Geode Capital Management LLC bought a new stake in shares of ENDRA Life Sciences in the 4th quarter worth approximately $71,000. Creative Planning acquired a new stake in ENDRA Life Sciences in the 4th quarter valued at approximately $53,000. Virtu Financial LLC increased its position in ENDRA Life Sciences by 109.2% in the 1st quarter. Virtu Financial LLC now owns 28,602 shares of the company’s stock valued at $47,000 after acquiring an additional 14,930 shares during the period. Finally, National Asset Management Inc. acquired a new stake in ENDRA Life Sciences in the 4th quarter valued at approximately $35,000. 17.17% of the stock is currently owned by institutional investors and hedge funds.

A number of research firms have commented on NDRA. Dougherty & Co started coverage on ENDRA Life Sciences in a report on Thursday. They set a “buy” rating on the stock. Lake Street Capital started coverage on ENDRA Life Sciences in a report on Monday, May 20th. They issued a “buy” rating on the stock.

COPYRIGHT VIOLATION WARNING: This article was first reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this article on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark law. The legal version of this article can be viewed at https://sportsperspectives.com/2019/06/13/endra-life-sciences-inc-nasdaqndra-director-buys-9500-shares-of-stock.html.

About ENDRA Life Sciences

ENDRA Life Sciences Inc develops medical imaging technology based on the thermos-acoustic effect that improves the sensitivity and specificity of clinical ultrasound. It offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding.

See Also: Put Option Volume

Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.